Francesca Vignani

1.4k total citations
46 papers, 750 citations indexed

About

Francesca Vignani is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Francesca Vignani has authored 46 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 24 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Francesca Vignani's work include Prostate Cancer Treatment and Research (21 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Francesca Vignani is often cited by papers focused on Prostate Cancer Treatment and Research (21 papers), Radiopharmaceutical Chemistry and Applications (9 papers) and Cancer Immunotherapy and Biomarkers (9 papers). Francesca Vignani collaborates with scholars based in Italy, United Kingdom and Belarus. Francesca Vignani's co-authors include Marcello Tucci, Giorgio V. Scagliotti, Massimo Di Maïo, Consuelo Buttigliero, Valentina Bertaglia, Paolo Bironzo, Clizia Zichi, Cristian Fiori, Francesco Porpiglia and Gianmarco Leone and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Francesca Vignani

42 papers receiving 746 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Vignani Italy 14 509 263 187 186 163 46 750
Lajos Géczi Hungary 16 460 0.9× 386 1.5× 203 1.1× 148 0.8× 124 0.8× 90 939
Georg Stüben Germany 20 624 1.2× 488 1.9× 193 1.0× 147 0.8× 155 1.0× 46 1.2k
Tiehong Zhang China 17 275 0.5× 280 1.1× 242 1.3× 162 0.9× 82 0.5× 36 712
Òscar Reig Spain 13 303 0.6× 218 0.8× 190 1.0× 153 0.8× 52 0.3× 56 562
Yoo‐Joung Ko Canada 11 620 1.2× 227 0.9× 264 1.4× 153 0.8× 92 0.6× 23 901
Liancheng Fan China 15 402 0.8× 270 1.0× 217 1.2× 201 1.1× 79 0.5× 38 691
C Mossetti Italy 13 350 0.7× 380 1.4× 131 0.7× 77 0.4× 79 0.5× 31 745
L. Rinnab Germany 15 404 0.8× 88 0.3× 298 1.6× 120 0.6× 146 0.9× 44 926
Yota Yasumizu Japan 18 367 0.7× 322 1.2× 419 2.2× 180 1.0× 113 0.7× 78 927
Sead Crnalic Sweden 19 775 1.5× 304 1.2× 412 2.2× 363 2.0× 90 0.6× 42 1.4k

Countries citing papers authored by Francesca Vignani

Since Specialization
Citations

This map shows the geographic impact of Francesca Vignani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Vignani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Vignani more than expected).

Fields of papers citing papers by Francesca Vignani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Vignani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Vignani. The network helps show where Francesca Vignani may publish in the future.

Co-authorship network of co-authors of Francesca Vignani

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Vignani. A scholar is included among the top collaborators of Francesca Vignani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Vignani. Francesca Vignani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Caterino, Marianna, Giorgio Lo Giudice, Vincenzo Damiano, et al.. (2025). Neutrophil/lymphocyte ratio: a potential biomarker in patients with head and neck squamous cell carcinoma treated with immune checkpoint inhibitors. Frontiers in Oncology. 15. 1557652–1557652.
2.
Fratino, Lucia, Jerry Polesel, Emilio Francesco Giunta, et al.. (2024). Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study. Scientific Reports. 14(1). 4949–4949.
3.
Maïo, Massimo Di, et al.. (2023). Poly (ADP-Ribose) Polymerase Inhibitors in Patients With Urothelial Cancer. Clinical Genitourinary Cancer. 21(5). 509–516. 2 indexed citations
4.
Palicelli, Andrea, et al.. (2023). Frequency of Germline and Somatic BRCA1 and BRCA2 Mutations in Prostate Cancer: An Updated Systematic Review and Meta-Analysis. Cancers. 15(9). 2435–2435. 15 indexed citations
5.
Stefano, Rosario Francesco Di, Marcello Tucci, Fabio Turco, et al.. (2021). Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate. Prostate Cancer and Prostatic Diseases. 24(3). 812–825. 3 indexed citations
6.
Bersanelli, Melissa, Giulia Mazzaschi, Patrizia Giannatempo, et al.. (2021). Immunotherapy and Sonpavde score validation in advanced upper tract urothelial carcinoma: a retrospective study by the Italian Network for Research in Urologic-Oncology (Meet-URO group). Immunotherapy. 14(2). 107–114. 2 indexed citations
7.
Leone, Gianmarco, Consuelo Buttigliero, Rosario Francesco Di Stefano, et al.. (2020). Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives. Critical Reviews in Oncology/Hematology. 152. 102994–102994. 11 indexed citations
8.
Buttigliero, Consuelo, Marcello Tucci, Cristina Sonetto, et al.. (2020). Prognostic role of early PSA drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide. Minerva Urologica e Nefrologica. 72(6). 737–745. 4 indexed citations
9.
Stefano, Rosario Francesco Di, Consuelo Buttigliero, Emmanuele De Luca, et al.. (2018). Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review. Clinical Genitourinary Cancer. 16(6). e1087–e1090. 4 indexed citations
10.
Nunno, Vincenzo Di, Emmanuele De Luca, Consuelo Buttigliero, et al.. (2018). Immune-checkpoint inhibitors in previously treated patients with advanced or metastatic urothelial carcinoma: A systematic review and meta-analysis. Critical Reviews in Oncology/Hematology. 129. 124–132. 13 indexed citations
11.
Tucci, Marcello, Gianmarco Leone, Consuelo Buttigliero, et al.. (2018). Hormonal treatment and quality of life of prostate cancer patients: new evidence. Minerva Urology and Nephrology. 70(2). 144–151. 39 indexed citations
12.
Masini, Cristina, Maria Giuseppa Vitale, Marco Maruzzo, et al.. (2018). Safety and Efficacy of Pazopanib in First-Line Metastatic Renal-Cell Carcinoma With or Without Renal Failure: CORE-URO-01 Study. Clinical Genitourinary Cancer. 17(1). e150–e155. 6 indexed citations
13.
Buttigliero, Consuelo, Marcello Tucci, Francesca Vignani, et al.. (2018). Chemotherapy-Induced Neutropenia and Outcome in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With First-Line Docetaxel. Clinical Genitourinary Cancer. 16(4). 318–324. 5 indexed citations
14.
Buttigliero, Consuelo, Marcello Tucci, Francesca Vignani, Giorgio V. Scagliotti, & Massimo Di Maïo. (2017). Molecular biomarkers to predict response to neoadjuvant chemotherapy for bladder cancer. Cancer Treatment Reviews. 54. 1–9. 45 indexed citations
15.
16.
17.
Vignani, Francesca, Valentina Bertaglia, Consuelo Buttigliero, et al.. (2016). Skeletal metastases and impact of anticancer and bone-targeted agents in patients with castration-resistant prostate cancer. Cancer Treatment Reviews. 44. 61–73. 52 indexed citations
18.
Iuliani, Michele, Francesco Pantano, Consuelo Buttigliero, et al.. (2015). Biological and clinical effects of abiraterone on anti-resorptive and anabolic activity in bone microenvironment. SHILAP Revista de lepidopterología. 11(4). 81–88.
19.
Tucci, Marcello, Valentina Bertaglia, Francesca Vignani, et al.. (2015). Addition of Docetaxel to Androgen Deprivation Therapy for Patients with Hormone-sensitive Metastatic Prostate Cancer: A Systematic Review and Meta-analysis. European Urology. 69(4). 563–573. 88 indexed citations
20.
Buttigliero, Consuelo, Marcello Tucci, Valentina Bertaglia, et al.. (2015). Understanding and overcoming the mechanisms of primary and acquired resistance to abiraterone and enzalutamide in castration resistant prostate cancer. Cancer Treatment Reviews. 41(10). 884–892. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lajos Géczi Breakdown of academic impact, for papers by Georg Stüben Breakdown of academic impact, for papers by Tiehong Zhang Breakdown of academic impact, for papers by Òscar Reig Breakdown of academic impact, for papers by Yoo‐Joung Ko Breakdown of academic impact, for papers by Liancheng Fan Breakdown of academic impact, for papers by C Mossetti Breakdown of academic impact, for papers by L. Rinnab Breakdown of academic impact, for papers by Yota Yasumizu Breakdown of academic impact, for papers by Sead Crnalic
Rankless by CCL
2026